Cibeles Moreno-Chico1,2, Luis González-de Paz3,4, Cristina Monforte-Royo1, Emilia Arrighi5, M Dolores Navarro-Rubio3,5, Alberto Gallart Fernández-Puebla1. 1. Department of Nursing, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain. 2. Rambla Mutua de Terrassa Primary Healthcare Centre, Terrassa, Barcelona, Spain. 3. Public Health and Epidemiology Unit, School of Medicine and Health Sciences, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain. 4. Consorci d'Atenció Primària Esquerra de l'Eixample, Transverse Group for Research in Primary Care, IDIBAPS, Barcelona, Spain. 5. Albert J. Jovell Institute for Public Health and Patients, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, Spain.
Abstract
Background: The 13-item Patient Activation Measure (PAM-13) is an instrument that assesses people's knowledge, skills and confidence for self-management of their health and health care. Scores on the PAM-13 have been shown to predict adherence to health behaviours, health-related outcomes and health care costs. Objectives: To develop a European Spanish adaptation of the original PAM-13 and to examine its psychometric properties in a sample of chronic patients. Methods: The PAM-13 was forward-backward translated and then completed by chronic patients attending a primary health care centre. Data were analysed with a Rasch model. We assessed the functioning of the rating scale, its reliability, the item goodness-of-fit, differential item functioning (DIF), local dependence, unidimensionality and correlation analysis. Results: A total of 208 patients (80%) completed the questionnaire. Data showed a fit to the Rasch model. More than 50% of patients endorsed all the items. Item rank for the Spanish sample was similar to the original, with few differences. We found significant differences (P < 0.05) in PAM-13 measures according to adherence to prescribed medicines and positive correlations with self-efficacy and physical quality of life. Conclusions: The European Spanish PAM-13 is a reliable and valid instrument for assessing activation in patients with chronic disease in Spain. We suggest adding new items to the instrument so as to examine patients with higher activation levels in the future. Further studies are needed to evaluate the usefulness of this new Spanish PAM-13 in different settings and populations, as well as to examine the relationship between PAM-13 scores and other health-related outcomes.
Background: The 13-item Patient Activation Measure (PAM-13) is an instrument that assesses people's knowledge, skills and confidence for self-management of their health and health care. Scores on the PAM-13 have been shown to predict adherence to health behaviours, health-related outcomes and health care costs. Objectives: To develop a European Spanish adaptation of the original PAM-13 and to examine its psychometric properties in a sample of chronic patients. Methods: The PAM-13 was forward-backward translated and then completed by chronic patients attending a primary health care centre. Data were analysed with a Rasch model. We assessed the functioning of the rating scale, its reliability, the item goodness-of-fit, differential item functioning (DIF), local dependence, unidimensionality and correlation analysis. Results: A total of 208 patients (80%) completed the questionnaire. Data showed a fit to the Rasch model. More than 50% of patients endorsed all the items. Item rank for the Spanish sample was similar to the original, with few differences. We found significant differences (P < 0.05) in PAM-13 measures according to adherence to prescribed medicines and positive correlations with self-efficacy and physical quality of life. Conclusions: The European Spanish PAM-13 is a reliable and valid instrument for assessing activation in patients with chronic disease in Spain. We suggest adding new items to the instrument so as to examine patients with higher activation levels in the future. Further studies are needed to evaluate the usefulness of this new Spanish PAM-13 in different settings and populations, as well as to examine the relationship between PAM-13 scores and other health-related outcomes.
Authors: Huijuan Zeng; Runsheng Jiang; Mei Zhou; Linxiong Wu; Bo Tian; Yao Zhang; Fanwei Qu Journal: J Int Med Res Date: 2019-10-10 Impact factor: 1.671
Authors: Lilisbeth Perestelo-Pérez; Amado Rivero-Santana; Vanesa Ramos-García; Yolanda Álvarez-Pérez; Andrea Duarte-Díaz; Alezandra Torres-Castaño; Maria Del Mar Trujillo-Martín; Tasmania Del Pino-Sedeño; Ana Isabel González-González; Pedro Serrano-Aguilar Journal: BMJ Open Date: 2020-12-10 Impact factor: 2.692
Authors: Rocío Rodríguez-Romero; Carles Falces; Belchin Kostov; Noemí García-Planas; Esther Blat-Guimerà; María C Alvira-Balada; Mireia López-Poyato; María L Benito-Serrano; Ingrid Vidiella-Piñol; Juan J Zamora-Sánchez; Marta Benet; Manuel V Garnacho-Castaño; Susana Santos-Ruiz; Rosalia Santesmases-Masana; Silvia Roura-Rovira; Jaume Benavent-Areu; Antoni Sisó-Almirall; Luis González-de Paz Journal: BMC Prim Care Date: 2022-05-06
Authors: Ana Isabel González-González; Lilisbeth Perestelo-Pérez; Débora Koatz; Marta Ballester; Valeria Pacheco-Huergo; Vanesa Ramos-García; Alezandra Torres-Castaño; Amado Rivero-Santana; Ana Toledo-Chávarri; Cristina Valcárcel-Nazco; Juana Mateos-Rodilla; Juan Carlos Obaya-Rebollar; Javier García-García; Santiago Díaz-Sánchez; Luis Morales-Cobos; Josep María Bosch-Fontcuberta; Nuria Vallejo-Camazón; Ana Rodríguez-Almodovar; José Carlos Del Castillo; Marcos Muñoz-Balsa; Yolanda Del Rey-Granado; Sofía Garrido-Elustondo; María-Eugenia Tello-Bernabé; Ana Belén Ramírez-Puerta; Carola Orrego Journal: BMJ Open Date: 2020-10-12 Impact factor: 2.692